|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2011-3-23
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Mass azithromycin distributions are used to clear ocular strains of chlamydia that cause trachoma, but treatments may also affect respiratory infections, diarrhea, and malaria. Here, we monitor a large cohort in which almost 90% of individuals received azithromycin. We assess whether receiving treatment is associated with reduced all-cause and infectious childhood mortality.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
883-8
|
|
pubmed:meshHeading |
pubmed-meshheading:21427395-Anti-Bacterial Agents,
pubmed-meshheading:21427395-Azithromycin,
pubmed-meshheading:21427395-Child,
pubmed-meshheading:21427395-Child, Preschool,
pubmed-meshheading:21427395-Child Mortality,
pubmed-meshheading:21427395-Cohort Studies,
pubmed-meshheading:21427395-Ethiopia,
pubmed-meshheading:21427395-Female,
pubmed-meshheading:21427395-Follow-Up Studies,
pubmed-meshheading:21427395-Humans,
pubmed-meshheading:21427395-Infant,
pubmed-meshheading:21427395-Infant Mortality,
pubmed-meshheading:21427395-Male,
pubmed-meshheading:21427395-Rural Population,
pubmed-meshheading:21427395-Trachoma
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Childhood mortality in a cohort treated with mass azithromycin for trachoma.
|
|
pubmed:affiliation |
F.I. Proctor Foundation, San Francisco, CA, USA. jeremy.keenan@ucsf.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
